Shares of Hemispherx BioPharma Inc. (AMEX: HEB) are
soaring in trading today after the company announced that Argentina’s national
regulator for drugs, food and medical technology, ANMAT, approved the sale and
distribution of Alferon N Injection® in the country.
Hemispherx BioPharma shares rose to an intra-day
high of $0.42 in trading today. At last check, the stock was trading more than
20% higher on above average volume. The rally has pushed Hemispherx shares
above their 50-day and 200-day moving averages.
To get more information on Hemispherx BioPharma Inc.
please click here…
